Decoy Therapeutics Inc. (DCOY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2450 Holcombe Blvd
Houston, TX 77021
United States of America (the)
Phone
1 617-314-9333
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11
First IPO Date
January 29, 2015
| Name | Title | Pay | Year Born |
| Frederick E. Pierce | CEO & Director | 217,523 | 1962 |
| Barbara Hibner | Chief Scientific Officer | 222,053 | 1962 |
| Peter K. Marschel | Chief Business Officer | 222,098 | 1975 |
| Mark J. Rosenblum | Executive VP of Finance & CFO | 569,000 | 1953 |
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.